Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,890.00
-70.00 (-2.36%)
At close: May 29, 2026

Remed Revenue

Remed had revenue of 7.18B KRW in the quarter ending March 31, 2026, with 11.37% growth. This brings the company's revenue in the last twelve months to 25.24B, down -5.41% year-over-year. In the year 2025, Remed had annual revenue of 24.50B, down -4.11%.

Revenue (ttm)
25.24B
Revenue Growth
-5.41%
P/S Ratio
3.54
Revenue / Employee
274.32M
Employees
92
Market Cap
89.32B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202524.50B-1.05B-4.11%
Dec 31, 202425.55B7.02B37.86%
Dec 31, 202318.54B-2.83B-13.23%
Dec 31, 202221.36B1.17B5.79%
Dec 31, 202120.20B3.56B21.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Genoray108.04B
DRGEM106.74B
JPI Healthcare47.97B
L&K Biomed39.53B
Hironic34.19B
SELVAS Healthcare30.19B
Dynamic solution16.05B
MEKICS CO.,12.26B
Revenue Rankings